These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 9168375

  • 1. OC practice guidelines: minimizing side effects.
    Darney PD.
    Int J Fertil Womens Med; 1997; Suppl 1():158-69. PubMed ID: 9168375
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral contraceptives.
    Shearman RP.
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U, Lambotte R.
    Bull Mem Acad R Med Belg; 1991 Sep; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [Abstract] [Full Text] [Related]

  • 7. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral contraceptives in 1984.
    Chapler EK.
    Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338
    [Abstract] [Full Text] [Related]

  • 10. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR.
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [Abstract] [Full Text] [Related]

  • 11. Rationale for new oral contraceptive dosing.
    Williams JK.
    Int J Fertil Womens Med; 2004 Jul; 49(1):30-5. PubMed ID: 15038507
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Oral contraception: failures and risks].
    Foussard-blanpin O, Paillot-renaud P, Bruneau-bigot A.
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [Abstract] [Full Text] [Related]

  • 14. [Cutaneous effects in hormonal contraception].
    Thomas P, Dalle E, Revillon B, Delecour M, Devarenne-nicolle MF, Pagniez I.
    NPN Med; 1985 Jan 01; 5(81):19-24. PubMed ID: 12281276
    [Abstract] [Full Text] [Related]

  • 15. [Metabolic risks of oral contraception].
    Monier L.
    Rev Int Pediatr; 1988 Feb 01; (178):64-5. PubMed ID: 12282576
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M.
    Acta Obstet Gynecol Scand Suppl; 1997 Feb 01; 164():63-5. PubMed ID: 9225641
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of oral contraceptives: fact vs. fiction.
    Contracept Rep; 1996 Jan 01; 6(6):4-14. PubMed ID: 12320011
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 01; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.